Evidence map›Paper›PMID 33454836›Full record

ReviewVirchows Archiv : an international journal of pathology2021

Primary MiNEN of the urinary bladder: an hitherto undescribed entity composed of large cell neuroendocrine carcinoma and adenocarcinoma with a distinct clinical behavior : Description of a case and review of the pertinent literature.

Giacomo Maria Pini, Silvia Uccella, Matteo Corinti, Maurizio Colecchia, Giuseppe Pelosi, Carlo Patriarca

Open access · hybridAbstract readCase ReportsReview
In one paragraph

Review in Virchows Archiv : an international journal of pathology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. The classification of neuroendocrine neoplasms of the breast and its clinical relevance.Virchows Archiv : an international journal of pathology · 2022
    Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Giacomo Maria PiniDepartment of Medicine and Surgery, Unit of Pathology, University of Insubria, via O. Rossi 9, 21100, Varese, Italy.
Silvia UccellaDepartment of Medicine and Surgery, Unit of Pathology, University of Insubria, via O. Rossi 9, 21100, Varese, Italy. silvia.uccella@uninsubria.it.ORCID http://orcid.org/0000-0002-5714-7295
Matteo CorintiDepartment of Urology, ASST Lariana, Como, Italy.
Maurizio ColecchiaDepartment of Pathology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Giuseppe PelosiDepartment of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.
Carlo PatriarcaDepartment of Pathology, ASST Lariana, Como, Italy.
Azienda Socio Sanitaria Territoriale Lariana · ITUniversity of Insubria · ITFondazione IRCCS Istituto Nazionale dei Tumori · ITUniversity of Milan · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neuroendocrine carcinomas (NECs) of the urinary bladder are very rare and can be observed in the context of mixed neuroendocrine/non-neuroendocrine neoplasms (MiNENs), most frequently in association with urothelial carcinoma. Small cell NECs are far more common than large cell NECs (LCNECs), which are exceedingly rare. We describe a primary MiNEN of the urinary bladder, composed of a LCNEC and of an adenocarcinoma, in which the neuroendocrine component reached complete pathological regression after neoadjuvant M-VAC chemotherapy, whereas the non-neuroendocrine component of the tumor progressed to metastatic disease. Compared to mixed neuroendocrine/non-neuroendocrine neoplasms described in the literature until now, this appears to be a unique case that expands the spectrum of neuroendocrine neoplasia of the urinary bladder.

Indexed as

AdenocarcinomaAntineoplastic Combined Chemotherapy ProtocolsCarcinoma, Large CellCarcinoma, NeuroendocrineCisplatinCystectomyDoxorubicinHumansMaleMethotrexateMiddle AgedNeoplasms, Complex and MixedProstatectomyTreatment OutcomeUrinary Bladder NeoplasmsVinblastineCisplatinDoxorubicinMethotrexateVinblastineMixed neuroendocrine/non-neuroendocrine neoplasmNeuroendocrine carcinomaNeuroendocrine neoplasmUrinary bladder

Identifiers

PMID33454836
PMCPMC8298318
OpenAlexW3121577422

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.